Try our Advanced Search for more refined results

July 07, 2016

Merck Sharp & Dohme Corp. v. Genentech, Inc. et al

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. July 08, 2016

    Merck Wants Genentech's Cancer Drug Patent Invalidated

    Merck & Co. Inc. filed a suit in California federal court on Thursday seeking a ruling that a key Genentech Inc. patent covering biotechnology used to make cancer drugs is invalid and that Merck's Keytruda melanoma and lung cancer treatment doesn't infringe the patent.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!